We have assembled the first comprehensive and integrated discovery, development and translational therapeutics company focused exclusively on inner ear disorders. Armed with unparalleled capabilities, tools and commitment, Decibel’s vision is to create a world where the benefits and joys of hearing are available to all.

We Are:

Hearing scientists working at the cutting edge of inner ear biology, genetics and genomics, bioinformatics and microsurgery

Drug developers with deep expertise in pharmacology, translational medicine and manufacturing who have filed more than 45 INDs and launched 17 therapies

Clinicians who have spent years treating hearing and balance disorders and are applying their expertise to clinical development

Entrepreneurs who have raised more than $5.5 billion in capital and successfully executed 4 IPOs

Our Leadership

Steve Holtzman headshot
John Keilty headshot
Paula Cobb headshot
John Lee headshot
Anna Trask headshot
Peter Weber headshot

Partnerships

We actively seek additional partnerships and in-licensing opportunities. If you would like to discuss an opportunity with Decibel, please contact Licensing@decibeltx.com

 

and additional undisclosed investors